Summary
This prediction ended on 20.08.18 with a price of €20.46. The price for Evotec SE massively increased, which is bad news for the SELL prediction by Markus86. Markus86 has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evotec SE | -8.472% | -8.472% | -72.299% | -85.365% |
| iShares Core DAX® | 2.722% | -4.863% | 12.025% | 9.678% |
| iShares Nasdaq 100 | 4.546% | -7.240% | 26.309% | 36.290% |
| iShares Nikkei 225® | 6.353% | -6.674% | 10.125% | 4.745% |
| iShares S&P 500 | 3.194% | -3.832% | 22.640% | 35.492% |
Comments by Markus86 for this prediction
In the thread Evotec AG diskutieren
Völlig überbewertet
Das Unternehmen bietet nichts das eine so hohe Bewertung rechtfertigen würde. Das Wachstum ist viel zu gering um ohne einen deutlichen Kursrückgang wieder auf ein angemessenes Niveau zu kommen.